1.00494
Parteck® M 100 (Mannitol)
EMPROVE® ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, E 421
동의어(들):
D-Mannitol
조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
보기 변경
제품정보 (DICE 배송 시 비용 별도)
실험식(Hill 표기법):
C6H14O6
CAS 번호:
Molecular Weight:
182.17
UNSPSC Code:
12352107
E Number:
E421
EC Index Number:
200-711-8
MDL number:
Quality Segment
agency
BP, ChP, JP, Ph. Eur., USP
product line
EMPROVE® ESSENTIAL
form
fine powder
autoignition temp.
410 °C
quality
E 421
particle size
(see specification)
pH
5-7 (20 °C, 100 g/L in H2O)
bp
290-295 °C/4 hPa
mp
164-169 °C
solubility
213 g/L
application(s)
liquid formulation
pharmaceutical
solid formulation
storage temp.
2-25°C
SMILES string
OC(C(O)C(O)CO)C(O)CO
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2
InChI key
FBPFZTCFMRRESA-UHFFFAOYSA-N
General description
With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
Parteck® M excipient achieves excellent compressibility while keeping the API stable throughout your manufacturing process and beyond. Based on directly compressible mannitol, it does not require further processing or high compression forces. The unique and large surface area of Parteck® M excipient enables rapid disintegration and quick release regardless of the dosage. It is well suitable for tableting processesusing direct compression or granulation techniques such as wet granulation androller compaction. Parteck® M is available in different particle sizes.
Features and Benefits
- High compactibility at low compression forces
- Rapid disintegration and fast dissolution
- High dilution potential
- Non-hygroscopic, exceptionally low content of reducing sugars
- Uniform doses with homogenous distribution
Legal Information
Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany
저장 등급
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Emprove® 프로그램을 사용하여 GMP 준수 유지
Emprove® Dossiers로 자격을 가속화하고, 규정 준수를 유지하며, 시간을 절약하세요.
Dossiers 다운로드
주: EmproveSuite.com으로 이동하게 됩니다. 귀하의 사용자 이름과 비밀번호는 시그마알드리치닷컴과는 별개이며 다를 수 있습니다.
무료로 등록하고 몇 분 안에 Emprove® Dossiers에 액세스하세요. 구독 플랜을 업그레이드하여 Emprove® Suite에서 고급 및 맞춤형 콘텐츠를 잠금 해제하세요.
원하는 정보를 찾지 못하셨나요? Emprove® 프로그램 도움말 페이지 방문하기.